Dissecting the genomic complexity underlying medulloblastoma

David Jones, Natalie Jäger, Marcel Kool, +84

Nature

Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis

Marco Francone, Franco Iafrate, Giorgio Maria Masci, +14

European Radiology

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients

Maria Giovanna Dal Bello, Rosangela Filiberti, Angela Alama, +13

Journal of Translational Medicine

Radiomic Detection of EGFR Mutations in NSCLC

Giovanni Rossi, Emanuele Barabino, Alessandro Fedeli, +15

Cancer Research

Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer

Selene Ottonello, Carlo Genova, Irene Cossu, +16

Frontiers in Immunology

Transcribed-ultra conserved region expression is associated with outcome in high-risk neuroblastoma

Paola Scaruffi, Sara Stigliani, Stefano Moretti, +6

BMC Cancer

Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome‐wide expression analysis and game theory

Domenico Albino, Paola Scaruffi, Stefano Moretti, +7

Cancer

Age‐dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma

Simona Coco, Paola Scaruffi, Sara Stigliani, +9

International Journal of Cancer

Numerical AberrationsTelomerase ActivityPathologyCell CycleHigh-grade Gliomas +19

Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab

Angela Alama, Simona Coco, Carlo Genova, +12

Journal of Clinical Medicine

Circulating Tumor DNA Reflects Tumor Metabolism Rather Than Tumor Burden in Chemotherapy-Naive Patients with Advanced Non–Small Cell Lung Cancer: ¹⁸F-FDG PET/CT Study

Silvia Morbelli, Angela Alama, Giulia Ferrarazzo, +13

Journal of Nuclear Medicine